Northern Trust’s Compass Therapeutics CMPX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.55M Buy
1,048,558
+75,623
+8% +$436K ﹤0.01% 2401
2025
Q4
$5.22M Buy
972,935
+111,000
+13% +$513K ﹤0.01% 2448
2025
Q3
$3.02M Buy
861,935
+127,241
+17% +$402K ﹤0.01% 2803
2025
Q2
$1.91M Sell
734,694
-68,444
-9% -$141K ﹤0.01% 3011
2025
Q1
$1.53M Buy
803,138
+1,913
+0.2% +$5.09K ﹤0.01% 3068
2024
Q4
$1.16M Sell
801,225
-43,164
-5% -$71.7K ﹤0.01% 3327
2024
Q3
$1.55M Buy
844,389
+96,825
+13% +$121K ﹤0.01% 3146
2024
Q2
$748K Sell
747,564
-19,347
-3% -$28.3K ﹤0.01% 3359
2024
Q1
$1.52M Buy
766,911
+7,178
+0.9% +$12.4K ﹤0.01% 3105
2023
Q4
$1.19M Sell
759,733
-65,381
-8% -$113K ﹤0.01% 3251
2023
Q3
$1.63M Buy
825,114
+55,249
+7% +$137K ﹤0.01% 3052
2023
Q2
$2.45M Buy
769,865
+584,562
+315% +$1.84M ﹤0.01% 2895
2023
Q1
$606K Buy
185,303
+28,220
+18% +$111K ﹤0.01% 3384
2022
Q4
$790K Buy
157,083
+69,716
+80% +$278K ﹤0.01% 3348
2022
Q3
$199K Buy
+87,367
New +$242K ﹤0.01% 3876

Other funds holding CMPX